Sumitomo Chemical Co (JP:4005) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Sumitomo Chemical Co. is set to transfer its shares in Nihon Medi-Physics Co. to GE HealthCare Ltd., expecting significant gains in its financial statements as a result. This strategic move aims to leverage GE HealthCare’s global expertise to boost Nihon Medi-Physics’ growth and competitiveness in the radiopharmaceuticals sector. The transfer, which will finalize by March 31, 2025, is anticipated to add approximately 30 billion yen to Sumitomo’s operating income.
For further insights into JP:4005 stock, check out TipRanks’ Stock Analysis page.
